Navigation Links
Active Life's BioDent Reference Point Indenter Validated in Study Published by Osteoporosis Medical Opinion Leaders
Date:1/24/2013

SANTA BARBARA, Calif., Jan. 24, 2013 /PRNewswire-iReach/ -- Top Osteoporosis researchers recently published a seminal paper showing that BioDent™ Reference Point Indentation measurements closely relate to toughness, a well-accepted mechanical measure of a bone's ability to resist breaking.   The research was completed at Indiana University / Purdue University in Indiana, led by Drs. David Burr and Max Gallant , and published in BONE, a leading academic journal. 

"A growing body of research has shown that Reference Point Indentation (RPI) data has a strong connection with identifying more and less easily fractured bone when bone density cannot," stated Active Life's Field Applications Scientist, Chris Mazzochi , PhD.  "However, this paper is the first to definitively report how BioDentTM measurements relate to the decades of historical data and knowledge from using conventional mechanical testing machines.  As a result of these and other comparable findings, BioDentTM is quickly becoming the gold standard for measuring the contribution of material properties to whole bone strength."

"Dr. Burr and his team have answered an extremely important question about RPI that will help progress the medical understanding of what causes bones to break in crippling diseases such as osteoporosis," said Active Life's Chief Executive Officer, Davis Brimer .  "Now that researchers know BioDentTM measurements are closely related to toughness as measured by conventional mechanical testers, academic labs and drug companies are more easily integrating BioDentTM into their existing and upcoming research projects and publications."

For more information on the publication visit http://www.activelifescientific.com/modules.php?name=Content&pa=showpage&pid=35  and click "Reference-point indentation correlates with bone toughness assessed using whole-bone traditional mechanical testing."

About BioDent™ Reference Point Indenter

The current application for BioDent™ RPI provides researchers with previously impossible means to assess the material properties of bone that resides in a living body (in vivo).  Among researchers it is generally understood that bone strength, the ability of a bone to resist breaking, depends on three things: 

  • How much bone material there is (bone mass/bone mineral density),
  • How well the bone material is put together (bone structure), and
  • How good that bone material is (bone material properties)

About Active Life Scientific, Inc.

Active Life Scientific, Inc. develops life science research and diagnostic tools that measure biological tissue quality.   These tools utilize novel biomarkers linked to the physical properties of tissues, such as how fibrous, elastic, or strong a tissue is.  The Company's products are based on world renowned inventor Dr. Paul Hansma 's latest breakthrough, Reference Point Indentation (RPI), with the unrivaled ability to quantify the quality of tissues that reside inside the living body (in vivo).  Active Life's flagship product, BioDent™, is utilized by key researchers who investigate and monitor diseased tissues and develop new treatments.  The Company currently supports bone research and is actively expanding applications for other tissues.  Active Life's mission is to provide life science and diagnostic tools that quantify tissue quality to enable accelerated drug development, cost-effective health care, and a better quality of life.

Media Contact: Davis Brimer Active Life Scientific, Inc., +1.805.770.2600 x101, davis@activelifescientific.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE Active Life Scientific, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. India Ophthalmic Devices Market Outlook to 2018 - Vision Care, Intraocular Lens (IOL), Cataract Surgery Devices, Ophthalmic Diagnostic Equipment, Refractive Surgery Devices, Vitreo Retinal Surgery Devices and Others
2. Active Pharmaceutical Ingredients (API) Global Market to 2017 - Growth in Developing Markets to Come From Cost Efficient Manufacturing and Rising Domestic Demand
3. Active Pharmaceutical Ingredients (API) Market in the Americas to 2017 - Shift Towards Generics and Biosimilars as South and Central America Emerges as a Key Growth Region
4. Phase 3 Data Show Intravenous Golimumab Inhibited Radiographic Progression in Patients with Active Rheumatoid Arthritis
5. AASLD Curriculum & Training (ACT) Launches With New Interactive HCV Education
6. Protalex, Inc. Announces Screening Of First Patients In U.S. For New Trial Of PRTX-100 In Patients With Active Rheumatoid Arthritis
7. ActiveCare Announces Record Revenue For Quarter Ending June 30, 2012
8. Global High Potency Active Pharmaceutical Ingredients (HPAPIs) Market is Expected to Reach USD 17.5 billion in 2018: Transparency Market Research
9. Active Life Announces Launch of Next Generation BioDentTM for Life Science Research
10. Soligenix Announces Issuance of US Patent for Topically Active Steroids to Treat Inflammatory Gastrointestinal Disorders
11. According to New Survey, Most Men are Not Proactive about Their Health Despite the Desire to Live Long Lives
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... , Feb. 23, 2017  Cogentix Medical, Inc. ... and markets innovative proprietary products for the urology market, ... fiscal year ended December 31, 2016 before the market ... The Company will host a conference call and webcast ... Thursday, March 9, 2017 at 11:00 a.m. Eastern Time ...
(Date:2/23/2017)... Feb 23, 2017 Research and Markets has announced ... 2016" report to their offering. ... The latest research Menopause Drugs Price Analysis and Strategies - ... The research answers the following questions: ... How are they positioned in the Global Menopause market? ...
(Date:2/23/2017)... 23, 2017 Research and Markets has announced ... - 2016" report to their offering. ... The latest research Fibromyalgia Drugs Price ... in the global Fibromyalgia market. The research answers the ... marketed for Fibromyalgia and their clinical attributes? How are they positioned ...
Breaking Medicine Technology:
(Date:2/23/2017)... ... February 23, 2017 , ... ... , media relations, content marketing, social media management, corporate communications, SEO and cause ... the state and in nearby New Hampshire, Massachusetts and Canada, Rosica will focus ...
(Date:2/23/2017)... Colorado (PRWEB) , ... February 23, 2017 , ... ... Magazine, an exciting, new, interactive publication where generations converge and explore the world ... expand their worldview, Dialog Magazine enables readers to gain understanding, increase empathy, and ...
(Date:2/23/2017)... , ... February 23, 2017 , ... ... new partnership with the Rhode Island Consortium for Autism Research and Treatment (RI-CART) ... for children with autism spectrum disorder (ASD) to see films in an environment ...
(Date:2/23/2017)... ... 2017 , ... Curemark, LLC announced today that the Blüm Study, a Phase ... 3-8 with Autism, is now enrolling at three new sites. These new sites are ... , “There are currently no approved drugs that address the core symptoms of ...
(Date:2/22/2017)... York (PRWEB) , ... February 22, 2017 , ... ... entrance and lobby of a new healthcare contact center in Georgia, PENETRON Specialty ... One of the nation’s largest healthcare systems recently invested $51 million to purchase ...
Breaking Medicine News(10 mins):